Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine for Orthostatic Intolerance in Parkinson's Disease
NCT02365012Unknown
- Sponsor
- Corporal Michael J. Crescenz VA Medical Center
- Start
- Apr 2014
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of midodrine in orthostatic intolerance (3 arms), sponsored by Corporal Michael J. Crescenz VA Medical Center. Primary endpoint: Non-Motor Symptoms Scale for Parkinson's Disease Domain I at 7 weeks. Status: unknown.
02
Drugs
midodrine
03
Conditions
orthostatic intolerance
Beyond the preview
Go deeper on NCT02365012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02365012.